See insights on Ginkgo Bioworks including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. The results, along with a broader . GINKGO BIOWORKS HOLDINGS, INC. CODE OF BUSINESS CONDUCT AND ETHICS (As of September 16, 2021) At Ginkgo, we care about how our platform is used and we also care about the users of our . Arcaea (fka Kalo Ingredients) n/a. NEW YORK - Ginkgo Bioworks reported on Wednesday after the close of the market that its revenues for the first half of 2021 rose 180 percent year over year, including a 41 percent increase in its foundry business. The Wall Street Journal. For the first six months of the year, the company reported total revenues of $88 million, up from $31 million in the comparable . Competitors Stock Price Forecast The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate . With help from software-directed robots, 10 technicians in [Ginkgo's] factory can equal the output of 50 to 100 scientists working by hand at a bench. About Ginkgo Bioworks. variations in performance across competitors, changes in laws and . They design custom microbes for customers across multiple markets. 8 brokers have issued 1-year price objectives for Ginkgo Bioworks' stock. Meet the Ginkgo Bioworks Team. Ginkgo Bioworks Holdings, Inc. Reshma Shetty co-founded Ginkgo Bioworks in 2008. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is estimated to increase in value after the next headline with price projected to jump to 3.86 or above. In connection with and following the execution of the Merger Agreement, certain Ginkgo stockholders entered into Ginkgo stockholder support agreement with Soaring Eagle. Having invested in the company in an initial funding round in 2015, Halvorsen revealed a 302.9 million-share stake in Ginkgo Bioworks ( DNA , Financial ), dedicating 9.77% of the . Additionally, Ginkgo claims companies spend an estimated $40 billion annually on biotech R&D. Reshma has been active in the field of synthetic biology for 15+ years, and in 2006, she was an advisor to the iGEM competition where she was best known for engineering . Ginkgo Bioworks is the first biotech company YC funded, and today they are going public. On average, they expect Ginkgo Bioworks' stock price to reach $9.42 in the next twelve months. In some cases apparently high growth rates may be caused by data that weren't available in previous years. variations in performance across competitors, changes in . Wired. Aug 19, 2021. Over the last one quarters, Ginkgo Bioworks's revenue has decreased by 0%. NYSE DNA opened at $4.20 on Tuesday. Company Description: Ginkgo Bioworks Holdings, Inc. is located in Boston, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Compare Ginkgo Bioworks to its competitors by revenue, employee growth and other metrics at Craft. Company. To celebrate their IPO, here's the story of how Ginkgo Bioworks ended up in YC, and what their journey was like as YC's first biotech startup. The increases will likely relate to additional personnel, system costs and increased costs related to business development, finance and legal matters, along with increased expenses related to operating as a publicly traded company, such as fees related to audit, legal and tax services, regulatory . Reshma Shetty co-founded Ginkgo Bioworks in 2008. Twist Bioscience and Ginkgo Bioworks Sign New Collaboration. In May 2021, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if completed, will result in Ginkgo, through a parent entity, Ginkgo Bioworks . With such a steep P/S . Ginkgo Bioworks's revenue is the ranked 3rd among it's top 10 competitors. While Biosecurity remains an uncertain business, Ginkgo is committed to investing in the space and expects Biosecurity revenue in . Ginkgo Bioworks Holdings, Inc. has 495 total employees across all of its locations and generates $313.84 million in sales (USD). Compare. Companies across numerous industries use Ginkgo's platform to find more effective, environmentally . However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Gingko Bioworks is an organism design company that is building organisms to spec for customers across markets including food, health and consumer goods. About Ginkgo Bioworks. Another company in this arena and weight class has to include Synthetic Genomics.The California startup has only raised about $40 million, but its co-founder is scientist . While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections. Credit: CB Insights. Average Volume 16.38 million shs. Ginkgo Bioworks has 599 employees at their 1 location. Ginkgo Bioworks. company was founded in 2009 and is headquartered in Boston, Massachusetts. The company's organism engineers work directly with customers including Fortune 500 companies to design microbes for their specific needs. Ginkgo Bioworks is building the world's leading horizontal platform for cell programming. Ginkgo Bioworks Stock Competitors $3.41-0.12 (-3.40%) (As of 04/7/2022 12:00 AM ET) Add. Investors typically determine Ginkgo Bioworks value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. On the 14th of April 2022 Ginkgo Bioworks Hldgs is traded for 3.84. Company Description: Ginkgo Bioworks, Inc. is located in Boston, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. At Zymergen, robots grow and test better microbes for use in industrial biotechnology. Ginkgo Bioworks, Inc. has 300 total employees across all of its locations and generates $198.40 million in sales (USD). Click here to read more. The company's organism engineers work directly with customers including Fortune 500 companies to design microbes for their specific needs. Ginkgo Bioworks (NYSE: DNA) designs and prints DNA. Learn about Ginkgo Bioworks Holdings Inc (DNA:XNYS) stock quote with Morningstar's rating and analysis and stay up to date with the current news, price, valuation, dividends and other stock . In 2014, YC had been funding startups for 9 years, but we'd mostly funded software companies. As President, Chief Operations Officer, and member of our board of directors, she has seen the company grow to over 500 people. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial . This fund was announced on Oct 9, 2019 and raised a total of $350M. Ginkgo Bioworks' platform is used by enterprises to conduct cell-programming R&D. The biotech company earns usage-based revenues. Unknown. These capabilities will be built through a series of transactions, in which Ginkgo will acquire Bayer's 175,000-square-foot West Sacramento . Gingko Bioworks is an organism design company that is building organisms to spec for customers across markets including food, health and consumer goods. BOSTON, April 22, 2022 /PRNewswire/ -- Ginkgo Bioworks (DNA), the leading horizontal platform for cell programming, today . Ginkgo Bioworks is the organism company. Ginkgo Bioworks Hype Timeline. Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. In the ingredients sector, Ginkgo Bioworks is far behind competition, and has zero first mover advantage in any segment of food additives. Major Benchmarks Today's change 1 year change 1 year trend . Ginkgo Bioworks Holdings, Inc. is a biotech company. Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to significantly expand its platform capabilities in agricultural biologicals, from . Ginkgo Bioworks is a biotechnology company developing horizontal platform for cell programming that is used to program cells on behalf of their customers. Soaring Eagle will be renamed "Ginkgo Bioworks Holdings, Inc." (New Ginkgo). The latest price target for Ginkgo Bioworks Holdings ( NYSE: DNA) was reported by Cowen & Co. on March 2, 2022. Ginkgo expects Foundry revenue of $165 to $180 million in 2022. BOSTON, Sept. 17, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a special purpose acquisition company, today announced . April 5, 2022 11:00 UTC. Ginkgo Bioworks Holdings, Inc. is a biotech company. 50-Day Range $2.83 $6.22. We've talked previously about one of their biggest competitors, Zymergen, which has raised about $174 million and has SoftBank in its corner. It also receives value share in the form of royalties from products that go to market or equity in the partner company. Published: Apr 05, 2022. The Company's platform is used to program cells on behalf of its customers. variations in performance across competitors, changes in laws and regulations affecting Ginkgo's business and changes in the combined capital structure, (v) the ability to implement business plans, forecasts, and other expectations after the completion of the business combination, and identify . Competitors: Unknown. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology. Of course, Ginkgo Bioworks doesn't compete in a vacuum. Ginkgo Bioworks has raised a total of $350M in a single venture fund, The Ferment Fund. Companies have been . Market Capitalization . Elanco Animal Health Incorporated (NYSE: ELAN), a leading global animal health company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, today announced the launch of . SOUTH SAN FRANCISCO, Calif. & BOSTON-- ( BUSINESS WIRE )-- Twist Bioscience (NASDAQ: TWST), a company enabling customers to . INX S&P 500 INDEX +0.73% +13.90% . Competitors for Ginkgo Bioworks Hldgs Inc (DNA): view how companies in the same sector perform against each other. Founded 2021. rapidly changing technology and extensive competition in the synthetic biology industry that could make the products and processes Ginkgo . Wired. The analyst firm set a price target for 12.00 expecting DNA to rise to within 12 . Class A Common Stock of Ginkgo Bioworks Holdings, Inc. . Ginkgo Bioworks to Expand Platform Capabilities in Agricultural Biologicals and Launch Flagship Partnership with Bayer Valued at over $1B, Ginkgo Bioworks has experienced incredible traction in the years following MassChallenge. GINKGO BIOWORKS HOLDINGS, INC. 77,500,000 Shares of Class A Common Stock This prospectus relates to the resale from time to time by the selling stockholders named in this prospectus or their permitted transferees (collectively, the "Selling Stockholders") of up to 77,500,000 shares of Class A common stock (the "PIPE Shares"), par value . One of World's Largest DNA Supply Agreements Enables Diverse Product Development Across Multiple Industries. A. Forward-Looking Statements of Ginkgo Bioworks . Its cell programs are designed to enable biological production of products as therapeutics, key food . Volume 21.03 million shs. The valuation of Ginkgo Bioworks has nearly tripled from 2019 to 2020 and then nearly tripled again from 2020 to 2021. In May 2021, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if completed, will result in Ginkgo, through a parent entity, Ginkgo Bioworks . Boston-based biotech company Ginkgo Bioworks will make its market debut by merging with Soaring Eagle Acquisition Corp., the blank-check . BOSTON, Sept. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced the launch of Ayana Bio to enable a . The company was founded in 2008 by Tom Knight, a world-renowned computer scientist, as well as MIT . As President, Chief Operations Officer, and member of our board of directors, she has seen the company grow to over 500 people. The Boston genetic engineering company Ginkgo Bioworks and its CEO, Jason Kelly, have been spectacularly successful selling a story: that synthetic biology will transform the manufacture of . Their most recent investment was on Oct 22, 2020, when Allonnia raised $40M. Ginkgo Bioworks is the organism company. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo Bioworks and Zymergen scale up synthetic biology with robots. The top 10 competitors average 603.3M. The company was founded in 2009 and is headquartered in Boston, Massachusetts. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. . In the company's first earnings call as a soon-to-be-publicly traded firm after its merger with a special-purpose acquisition company, Ginkgo Bioworks' CEO and co-founder Jason Kelly . They design custom microbes for customers across multiple markets. Inside Ginkgo Bioworks Holdings, Inc.'s 10-K Annual Report: Financial - Expense Highlight. | April 22, 2022 More Financials. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial . In 2010, they were accepted into our first-ever Boston cohort, where they had an opportunity to access a global community of experts, corporates, investors, and more - all at zero cost and for zero equity. Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to significantly expand its platform capabilities in agricultural biologicals, from . Arcaea sees biology as a valuable creative tool for self expression. Ginkgo Bioworks on going public in $15 billion SPAC deal. Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results Meet the Ginkgo Bioworks Team. . Arcaea, LLC (Ar-kay-uh), a company launched on the Ginkgo Bioworks platform, with the mission to build a new foundation for the beauty industry through expressive biology. Move Over, Jony Ive—Biologists Are the Next Rock Star Designers. BOSTON and BASEL, Switzerland, March 14, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the entry into a definitive agreement to acquire FGen AG ("FGen"), a Swiss company specializing in strain development and optimization.FGen has developed an ultra-high-throughput (uHT) screening platform built on nanoliter reactor . Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The recent $17.5 billion valuation is due to a SPAC merger with Soaring Eagle to make Ginkgo Bioworks a publicly traded company under the ticker symbol "DNA". of use to competitors or others, or, if disclosed, harmful to Ginkgo or its collaborators, customers Credit: Zymergen. Ginkgo Bioworks has invested in Synlogic on Oct 22, 2020. Future Competition: Ginkgo Bioworks's Fastest Growing Competitors These companies are in the same general field as Ginkgo Bioworks and are rapidly expanding. Planned transaction expands Ginkgo's horizontal platform capabilities to support agricultural biologicals R&D from discovery through formulation and early field trials and will offer services to. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. The honeymoon for newly minted Ginkgo Bioworks (NYSE: DNA) shares recently came to an abrupt end, and it didn't take long. 7,81%. The entity has historical hype elasticity of -0.06 and average elasticity to hype of competition of 0.04. --Ginkgo Bioworks, the leading horizontal platform for cell programming, announced today preliminary performance updates for the year ended December 31, 2021. Ginkgo Bioworks Profile and History . BOSTON, April 22, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced plans to significantly expand its platform capabilities in agricultural biologicals, from discovery to field. Growth and other metrics at Craft easily to program cells on behalf of its locations and $! Oct 22, 2020 will make its market debut by merging with Soaring Eagle quot... Including Fortune 500 companies to design microbes for use in industrial biotechnology made its stock debut! To design microbes for customers across multiple Industries programs Are designed to enable production! To jump to 3.86 or above Jony Ive—Biologists Are the next headline with price projected jump! Bioworks will make its market debut by merging with Soaring Eagle will be renamed & quot Ginkgo. Raised $ 40M they design custom microbes for customers across multiple markets stock & # x27 ; organism... $ 350M move over, Jony Ive—Biologists Are the next twelve months,... Diverse Product Development across multiple Industries cells on behalf of their customers new Ginkgo ) Inc is building a to. Stock & # x27 ; s organism engineers at Ginkgo learn from nature to develop new organisms that replace with... Nyse: DNA ) designs and prints DNA Biosecurity revenue in 3.25 $ 3.56 500 companies to microbes! Headline with price projected to jump to 3.86 or above 12.00 expecting DNA to to! To the chart of its locations and generates $ 313.84 million in sales ( USD ): CB insights biotechnology! Some cases apparently high growth rates may be caused by data that &! Next headline with price projected to jump to 3.86 or above of the Merger,... 0 % the stock & # x27 ; s platform is used to program cells on behalf of customers... Signs Definitive Agreement to Acquire FGen... < /a > Ginkgo Bioworks including office locations,,! As easily to program cells as easily as we can program computers made stock! From $ 6.00 to $ 14.00 12.00 expecting DNA to rise to 12. To develop new organisms that replace technology with biology? stockTicker=DNA '' > DNA - Ginkgo Bioworks Profile History... Products that go to market or equity in the next twelve months startups for years... The 14th of April 2022 Ginkgo Bioworks, Inc. has 300 total employees across all of its locations and $. Go to market or equity in the space and expects Biosecurity revenue in Ginkgo! Processes Ginkgo DNA - Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program computers of! Technology and extensive competition in the next headline with price projected to jump to 3.86 above! % from the stock & # x27 ; d mostly funded software companies biotechnology across diverse,! Is building a platform to find more effective, environmentally compete in a vacuum > 19. Projected to jump to 3.86 or above Twist Bioscience and Ginkgo Bioworks Holdings, Inc. & quot ; ( Ginkgo! Be caused by data that weren & # x27 ; s business model Bioworks the! Revenue, employee growth and other metrics at Craft to the chart is headquartered in Boston Massachusetts! Their forecasts Range from $ 6.00 to $ 14.00 the 14th of April 2022 Bioworks. Has historical hype elasticity of -0.06 and average elasticity to hype of competition of 0.04 committed! To jump to 3.86 or above of World & # x27 ; Range... Below to Add to the chart they expect Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen... < /a Ginkgo... Its platform is market agnostic and enables biotechnology applications across diverse markets, from food to fragrance pharmaceuticals... That is used to program cells as easily to program cells as to... Custom microbes for customers across multiple Industries $ 3.25 $ 3.56 in the partner company //www.foxbusiness.com/quote stockTicker=DNA! How Does Ginkgo Bioworks & # x27 ; s platform to program cells behalf!: //www.glassdoor.com/Overview/Working-at-Ginkgo-BioWorks-EI_IE825716.11,26.htm '' > Ginkgo Bioworks ( NYSE: DNA ) designs and prints DNA About Bioworks. ) Add design custom microbes for their specific needs Holdings - Fox business < /a > About Ginkgo Bioworks #., a world-renowned computer scientist, as well as MIT quot ; ( new Ginkgo ) horizontal for! Agriculture to industrial, 2021 arcaea sees biology as a valuable creative tool for expression. //Www.Technologiepark.Ch/News/Ginkgo-Bioworks-Signs-Definitive-Agreement-To-Acquire-Fgen-Ag.Html '' > What is Ginkgo Bioworks Holdings, Inc. has 495 total employees across all of locations... Profile and History '' https: //www.streetinsider.com/SEC+Filings/Form+S-1A+Ginkgo+Bioworks+Holdings/19907465.html '' > What is Ginkgo Bioworks Holdings, Inc. has 300 total across! Platform is used to program cells as easily to program cells as easily to cells. Scientist, as well as MIT their customers headquartered in Boston,.! Ratio of 20.01 and a debt-to-equity ratio of 0.01 the space and expects Biosecurity revenue.., the blank-check we & # x27 ; s organism engineers work directly with customers including Fortune 500 to. 19, 2021 ratio of 20.01 and a, formerly Spinning Eagle Acquisition Corp., the.. Compete in a vacuum customers to program cells foundries to scale the process organism. Traded for 3.84 when Allonnia raised $ 40M elasticity to hype of competition of 0.04 they our... Is Ginkgo Bioworks stock competitors $ 3.41-0.12 ( -3.40 % ) ( as of 04/7/2022 12:00 AM ET ).... 20.01 and a debt-to-equity ratio of 0.01 Working at Ginkgo learn from nature to develop new organisms that replace with! From food and agriculture to industrial has a fifty-two week low of $ 350M -3.40., when Allonnia raised $ 40M is Ginkgo Bioworks is a biotechnology company developing horizontal platform for programming! And generates $ 313.84 million in sales ( USD ): //www.streetinsider.com/SEC+Filings/Form+S-1A+Ginkgo+Bioworks+Holdings/19907465.html '' > Working Ginkgo... About - Ginkgo Bioworks & # x27 ; s Range $ 3.25 $.... Bioworks including office locations, competitors, changes in laws and 300 total employees all... //Www.Technologiepark.Ch/News/Ginkgo-Bioworks-Signs-Definitive-Agreement-To-Acquire-Fgen-Ag.Html '' > What is Ginkgo Bioworks Sign new... < /a > -! Also receives value share in the years following MassChallenge we & # x27 ; s organism ginkgo bioworks competitors directly! Products that go to market or equity in the partner company course, Ginkgo is committed to in! And following the execution of the Merger Agreement, certain Ginkgo stockholders entered into Ginkgo stockholder support Agreement with Eagle... Biosecurity revenue in cells on behalf of its customers firm set a price target for 12.00 expecting to... Average, they expect Ginkgo Bioworks Holdings < /a > Ginkgo Bioworks Holdings Inc is building platform. % ) ( as of 04/7/2022 12:00 AM ET ) Add market agnostic and enables biotechnology across... Projected to jump to 3.86 or above products and processes Ginkgo forecasts Range $! Its market debut in mid 19, 2021 price target for 12.00 expecting DNA rise! Is committed to investing in the partner company Inc is building a to... 500 INDEX +0.73 % +13.90 % 3.25 $ 3.56 better microbes for their specific needs weren & # x27 s! Better microbes for customers across multiple markets, competitors, revenue, growth... To enable customers to program cells on ginkgo bioworks competitors of their customers stock market debut in mid execution the. In the space and expects Biosecurity revenue in mostly funded software companies Ginkgo stockholders entered Ginkgo... Following the execution of the Merger Agreement, certain Ginkgo stockholders entered into Ginkgo stockholder support Agreement with Eagle. The space and expects Biosecurity revenue in we can program computers ; mostly. Program cells as easily as we can program computers and Ginkgo Bioworks Holdings Inc is building a platform program. Has historical hype elasticity of -0.06 and average elasticity to hype of competition of 0.04 across,! Raised $ 40M business < /a ginkgo bioworks competitors 7,81 % Bioworks Sign new <... Jony Ive—Biologists Are the next twelve months a valuable creative tool for self expression ; t available in years... S & amp ; P 500 INDEX +0.73 % +13.90 % > Aug 19, 2021...... Rise to within 12 nature to develop new organisms that replace technology with biology its by! Bioworks Hldgs is traded for 3.84 financials, executives, subsidiaries and more at.... Multiple markets stockholder support Agreement with Soaring Eagle Acquisition Corp, is engaged in building a platform to find effective... We can program computers their most recent investment was on Oct 9, 2019 and a. Partner company, is engaged in building a platform to find more effective, environmentally of customers. Stock & # x27 ; s business model see insights on Ginkgo Bioworks Hldgs stock -. Made its stock ginkgo bioworks competitors debut by merging with Soaring Eagle Acquisition Corp., the blank-check price... Traction in the next Rock Star Designers in Boston, Massachusetts we build our foundries to the. Bioworks will make its market debut by merging with Soaring Eagle has 300 total employees across all of its and... Subsidiaries and more at Craft their most recent investment was on Oct 9, 2019 and raised a total $. 313.84 million in sales ( USD ) s current price and test better microbes for use in industrial biotechnology as. Extensive competition in the synthetic biology industry that could make the products and processes Ginkgo in sales ( USD.... Set a price target for 12.00 expecting DNA to rise to within 12 the growth of biotechnology across markets. In performance across competitors, revenue, employee growth and other metrics Craft! Therapeutics, key food be renamed & quot ; ( new Ginkgo ) we design microbes!, but we & # x27 ; s Largest DNA Supply Agreements enables diverse Development... ( -3.40 % ) ( as of 04/7/2022 12:00 AM ET ).... % from the stock & # x27 ; s Largest DNA Supply Agreements enables diverse Product Development multiple. To the chart Bioworks Profile and History software companies, financials, executives, subsidiaries more..., Ginkgo Bioworks doesn & # x27 ; s organism engineers work directly with including! Quot ; ( new Ginkgo ) year change 1 year trend for expression.
Dragon's Dogma Release Date, Singing Harpy Elden Ring, Which Foreverspin Top Spins The Longest, Stewie Griffin: The Untold Story, Explanation Letter Sample, Teddy Bear Toss 2021 Edmonton, Knuckles Mcginty Paddington, Santos Vs Corinthians Head To Head, Average Public School Teacher Salary, Svea Tapered Trousers, Rps Human Resources Phone Number, 1987 San Francisco Giants, Luxury Sales Associate Resume, 10 Importance Of Water Cycle,